Clinical Trials Browser

NIH × pirtobrutinib × Other hematologic neoplasm × Clear all

NCT07428707 2026-06-04

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell